327 related articles for article (PubMed ID: 22513409)
21. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
[TBL] [Abstract][Full Text] [Related]
22. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
[TBL] [Abstract][Full Text] [Related]
23. p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.
Meijers BK; De Loor H; Bammens B; Verbeke K; Vanrenterghem Y; Evenepoel P
Clin J Am Soc Nephrol; 2009 Dec; 4(12):1932-8. PubMed ID: 19833905
[TBL] [Abstract][Full Text] [Related]
24. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
25. Indoxyl sulfate, not p-cresyl sulfate, is associated with cognitive impairment in early-stage chronic kidney disease.
Yeh YC; Huang MF; Liang SS; Hwang SJ; Tsai JC; Liu TL; Wu PH; Yang YH; Kuo KC; Kuo MC; Chen CS
Neurotoxicology; 2016 Mar; 53():148-152. PubMed ID: 26797588
[TBL] [Abstract][Full Text] [Related]
26. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
[TBL] [Abstract][Full Text] [Related]
27. Role of Organic Anion Transporters in the Uptake of Protein-Bound Uremic Toxins by Human Endothelial Cells and Monocyte Chemoattractant Protein-1 Expression.
Favretto G; Souza LM; Gregório PC; Cunha RS; Maciel RAP; Sassaki GL; Toledo MG; Pecoits-Filho R; Souza WM; Stinghen AEM
J Vasc Res; 2017; 54(3):170-179. PubMed ID: 28472795
[TBL] [Abstract][Full Text] [Related]
28. Biophysical insight into furosemide binding to human serum albumin: a study to unveil its impaired albumin binding in uremia.
Zaidi N; Ahmad E; Rehan M; Rabbani G; Ajmal MR; Zaidi Y; Subbarao N; Khan RH
J Phys Chem B; 2013 Mar; 117(9):2595-604. PubMed ID: 23438181
[TBL] [Abstract][Full Text] [Related]
29. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
Watanabe H
Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
[TBL] [Abstract][Full Text] [Related]
30. Circulating
Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
[TBL] [Abstract][Full Text] [Related]
31. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
[TBL] [Abstract][Full Text] [Related]
32. Protein-bound molecules: a large family with a bad character.
Sirich TL; Meyer TW; Gondouin B; Brunet P; Niwa T
Semin Nephrol; 2014 Mar; 34(2):106-17. PubMed ID: 24780467
[TBL] [Abstract][Full Text] [Related]
33. p-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways.
Tanaka H; Iwasaki Y; Yamato H; Mori Y; Komaba H; Watanabe H; Maruyama T; Fukagawa M
Bone; 2013 Oct; 56(2):347-54. PubMed ID: 23851293
[TBL] [Abstract][Full Text] [Related]
34. In-situ synchrotron imaging, experimental, and computational investigations on the efficiency of Trametes versicolor laccase on detoxification of P-Cresyl Sulfate (PCS) Protein Bound Uremic Toxin (PBUT).
Sadaati S; Daneshamouz S; Bahig J; Shoker A; Abdelrasoul A
J Biotechnol; 2023 May; 368():12-30. PubMed ID: 37004788
[TBL] [Abstract][Full Text] [Related]
35. Quantitative Translation of Microfluidic Transporter
van der Made TK; Fedecostante M; Scotcher D; Rostami-Hodjegan A; Sastre Toraño J; Middel I; Koster AS; Gerritsen KG; Jankowski V; Jankowski J; Hoenderop JGJ; Masereeuw R; Galetin A
Mol Pharm; 2019 Nov; 16(11):4551-4562. PubMed ID: 31525064
[TBL] [Abstract][Full Text] [Related]
36. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
37. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
38. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
[TBL] [Abstract][Full Text] [Related]
39. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
40. Targeting protein-bound uremic toxins in chronic kidney disease.
Niwa T
Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
